Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research Oncology/Hematology Market Research

Global Anti-Cancer Drug Databank Market Report

Best Price Guarantee Length Publisher Published Date SKU
from $2,000 100 Pages Magna Intelligence April, 2024 MAIN18740200
Best Price Guarantee
Price from $2,000
Length 100 Pages
Publisher Magna Intelligence
Published Date April, 2024
SKU MAIN18740200

Global Anti-Cancer Drug Databank Market Report


The Anti-Cancer Drug market was valued at $131,524.6 Million in 2022, and is projected to reach $217,811.8 Million by 2031 growing at a CAGR of 5.81% from 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $43,423.4 Million in 2022, and is anticipated to reach $75,119.7 Million by 2031, registering a CAGR of 6.32%. Hormonal Therapy segment is anticipated to reach $27,309.8 Million by 2031 with the highest CAGR of 6.89%. Targeted Therapy and Immunotherapy segments collectively expected to account for about 61.1% share of the Anti-Cancer Drug market in 2022, with the former constituting around 33.0% share. Hormonal Therapy and Targeted Therapy segments are expected to witness significant growth rates at a CAGR of 6.89% and 6.32% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 44.5% in the overall Anti-Cancer Drug market in 2022, and is anticipated to reach 47.0% by 2031.


1. Global Anti-Cancer Drug Market, By Drug Class
1.1. Overview
1.2. Chemotherapy
1.2.1 Chemotherapy Market, By Region
1.2.1.1 North America Chemotherapy Market, By Country
1.2.1.2 Europe Chemotherapy Market, By Country
1.2.1.3 Asia-Pacific Chemotherapy Market, By Country
1.2.1.4 Rest of World Chemotherapy Market, By Country
1.3. Targeted Therapy
1.3.1 Targeted Therapy Market, By Region
1.3.1.1 North America Targeted Therapy Market, By Country
1.3.1.2 Europe Targeted Therapy Market, By Country
1.3.1.3 Asia-Pacific Targeted Therapy Market, By Country
1.3.1.4 Rest of World Targeted Therapy Market, By Country
1.4. Immunotherapy
1.4.1 Immunotherapy Market, By Region
1.4.1.1 North America Immunotherapy Market, By Country
1.4.1.2 Europe Immunotherapy Market, By Country
1.4.1.3 Asia-Pacific Immunotherapy Market, By Country
1.4.1.4 Rest of World Immunotherapy Market, By Country
1.5. Hormonal Therapy
1.5.1 Hormonal Therapy Market, By Region
1.5.1.1 North America Hormonal Therapy Market, By Country
1.5.1.2 Europe Hormonal Therapy Market, By Country
1.5.1.3 Asia-Pacific Hormonal Therapy Market, By Country
1.5.1.4 Rest of World Hormonal Therapy Market, By Country
2. Global Anti-Cancer Drug Market, By Indication
2.1. Overview
2.2. Lung Cancer
2.2.1 Lung Cancer Market, By Region
2.2.1.1 North America Lung Cancer Market, By Country
2.2.1.2 Europe Lung Cancer Market, By Country
2.2.1.3 Asia-Pacific Lung Cancer Market, By Country
2.2.1.4 Rest of World Lung Cancer Market, By Country
2.3. Stomach Cancer
2.3.1 Stomach Cancer Market, By Region
2.3.1.1 North America Stomach Cancer Market, By Country
2.3.1.2 Europe Stomach Cancer Market, By Country
2.3.1.3 Asia-Pacific Stomach Cancer Market, By Country
2.3.1.4 Rest of World Stomach Cancer Market, By Country
2.4. Colorectal Cancer
2.4.1 Colorectal Cancer Market, By Region
2.4.1.1 North America Colorectal Cancer Market, By Country
2.4.1.2 Europe Colorectal Cancer Market, By Country
2.4.1.3 Asia-Pacific Colorectal Cancer Market, By Country
2.4.1.4 Rest of World Colorectal Cancer Market, By Country
2.5. Breast Cancer
2.5.1 Breast Cancer Market, By Region
2.5.1.1 North America Breast Cancer Market, By Country
2.5.1.2 Europe Breast Cancer Market, By Country
2.5.1.3 Asia-Pacific Breast Cancer Market, By Country
2.5.1.4 Rest of World Breast Cancer Market, By Country
2.6. Prostate Cancer
2.6.1 Prostate Cancer Market, By Region
2.6.1.1 North America Prostate Cancer Market, By Country
2.6.1.2 Europe Prostate Cancer Market, By Country
2.6.1.3 Asia-Pacific Prostate Cancer Market, By Country
2.6.1.4 Rest of World Prostate Cancer Market, By Country
2.7. Liver Cancer
2.7.1 Liver Cancer Market, By Region
2.7.1.1 North America Liver Cancer Market, By Country
2.7.1.2 Europe Liver Cancer Market, By Country
2.7.1.3 Asia-Pacific Liver Cancer Market, By Country
2.7.1.4 Rest of World Liver Cancer Market, By Country
2.8. Esophagus Cancer
2.8.1 Esophagus Cancer Market, By Region
2.8.1.1 North America Esophagus Cancer Market, By Country
2.8.1.2 Europe Esophagus Cancer Market, By Country
2.8.1.3 Asia-Pacific Esophagus Cancer Market, By Country
2.8.1.4 Rest of World Esophagus Cancer Market, By Country
2.9. Cervical Cancer
2.9.1 Cervical Cancer Market, By Region
2.9.1.1 North America Cervical Cancer Market, By Country
2.9.1.2 Europe Cervical Cancer Market, By Country
2.9.1.3 Asia-Pacific Cervical Cancer Market, By Country
2.9.1.4 Rest of World Cervical Cancer Market, By Country
2.10. Kidney Cancer
2.10.1 Kidney Cancer Market, By Region
2.10.1.1 North America Kidney Cancer Market, By Country
2.10.1.2 Europe Kidney Cancer Market, By Country
2.10.1.3 Asia-Pacific Kidney Cancer Market, By Country
2.10.1.4 Rest of World Kidney Cancer Market, By Country
2.11. Bladder Cancer
2.11.1 Bladder Cancer Market, By Region
2.11.1.1 North America Bladder Cancer Market, By Country
2.11.1.2 Europe Bladder Cancer Market, By Country
2.11.1.3 Asia-Pacific Bladder Cancer Market, By Country
2.11.1.4 Rest of World Bladder Cancer Market, By Country
2.12. Other Indications
2.12.1 Other Indications Market, By Region
2.12.1.1 North America Other Indications Market, By Country
2.12.1.2 Europe Other Indications Market, By Country
2.12.1.3 Asia-Pacific Other Indications Market, By Country
2.12.1.4 Rest of World Other Indications Market, By Country
3. Global Anti-Cancer Drug Market, By Region
3.1. Overview
3.2. North America
3.2.1 North America Anti-Cancer Drug Market, By Drug Class
3.2.2 North America Anti-Cancer Drug Market, By Indication
3.2.3 North America Anti-Cancer Drug Market, By Country
3.2.3.1 U.S.
3.2.3.1.1 U.S. Anti-Cancer Drug Market, By Drug Class
3.2.3.1.2 U.S. Anti-Cancer Drug Market, By Indication
3.2.3.2 Canada
3.2.3.2.1 Canada Anti-Cancer Drug Market, By Drug Class
3.2.3.2.2 Canada Anti-Cancer Drug Market, By Indication
3.3. Europe
3.3.1 Europe Anti-Cancer Drug Market, By Drug Class
3.3.2 Europe Anti-Cancer Drug Market, By Indication
3.3.3 Europe Anti-Cancer Drug Market, By Country
3.3.3.1 Germany
3.3.3.1.1 Germany Anti-Cancer Drug Market, By Drug Class
3.3.3.1.2 Germany Anti-Cancer Drug Market, By Indication
3.3.3.2 U.K.
3.3.3.2.1 U.K. Anti-Cancer Drug Market, By Drug Class
3.3.3.2.2 U.K. Anti-Cancer Drug Market, By Indication
3.3.3.3 France
3.3.3.3.1 France Anti-Cancer Drug Market, By Drug Class
3.3.3.3.2 France Anti-Cancer Drug Market, By Indication
3.3.3.4 Italy
3.3.3.4.1 Italy Anti-Cancer Drug Market, By Drug Class
3.3.3.4.2 Italy Anti-Cancer Drug Market, By Indication
3.3.3.5 Spain
3.3.3.5.1 Spain Anti-Cancer Drug Market, By Drug Class
3.3.3.5.2 Spain Anti-Cancer Drug Market, By Indication
3.3.3.6 Rest of Europe
3.3.3.6.1 Rest of Europe Anti-Cancer Drug Market, By Drug Class
3.3.3.6.2 3.4.
Asia-Pacific 3.4.1
Asia-Pacific Anti-Cancer Drug Market, By Drug Class 3.4.2
Asia-Pacific Anti-Cancer Drug Market, By Indication 3.4.3
Asia-Pacific Anti-Cancer Drug Market, By Country 3.4.3.1
China 3.4.3.1.1
China Anti-Cancer Drug Market, By Drug Class 3.4.3.1.2
China Anti-Cancer Drug Market, By Indication 3.4.3.2
Japan 3.4.3.2.1
Japan Anti-Cancer Drug Market, By Drug Class 3.4.3.2.2
Japan Anti-Cancer Drug Market, By Indication 3.4.3.3
South Korea 3.4.3.3.1
South Korea Anti-Cancer Drug Market, By Drug Class 3.4.3.3.2
South Korea Anti-Cancer Drug Market, By Indication 3.4.3.4
India 3.4.3.4.1
India Anti-Cancer Drug Market, By Drug Class 3.4.3.4.2
India Anti-Cancer Drug Market, By Indication 3.4.3.5
Singapore 3.4.3.5.1
Singapore Anti-Cancer Drug Market, By Drug Class 3.4.3.5.2
Singapore Anti-Cancer Drug Market, By Indication 3.4.3.6
Rest of Asia 3.4.3.6.1
Rest of Asia Anti-Cancer Drug Market, By Drug Class 3.4.3.6.2
Rest of Asia Anti-Cancer Drug Market, By Indication 3.5.
Rest of World 3.5.1
Rest of World Anti-Cancer Drug Market, By Drug Class 3.5.2
Rest of World Anti-Cancer Drug Market, By Indication 3.5.3
Rest of World Anti-Cancer Drug Market, By Country 3.5.3.1
Brazil 3.5.3.1.1
Brazil Anti-Cancer Drug Market, By Drug Class 3.5.3.1.2
Brazil Anti-Cancer Drug Market, By Indication 3.5.3.2
Mexico 3.5.3.2.1
Mexico Anti-Cancer Drug Market, By Drug Class 3.5.3.2.2
Mexico Anti-Cancer Drug Market, By Indication 3.5.3.3
South Africa 3.5.3.3.1
South Africa Anti-Cancer Drug Market, By Drug Class 3.5.3.3.2
South Africa Anti-Cancer Drug Market, By Indication 3.5.3.4
Australia 3.5.3.4.1
Australia Anti-Cancer Drug Market, By Drug Class 3.5.3.4.2
Australia Anti-Cancer Drug Market, By Indication 3.5.3.5
ROW Countries 3.5.3.5.1
ROW Countries Anti-Cancer Drug Market, By Drug Class 3.5.3.5.2
ROW Countries Anti-Cancer Drug Market, By Indication ROW Countries Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USDLIST OF TABLES
TABLE 1. Global Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 2. Chemotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Targeted Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Targeted Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 12. Immunotherapy Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD
TABLE 17. Hormonal Therapy Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 19. Europe Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 20. Asia-Pacific Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 21. Rest of World Hormonal Therapy Market Value, By Country, 2022-2031, Million USD
TABLE 22. Global Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 23. Lung Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 24. North America Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 25. Europe Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 26. Asia-Pacific Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 27. Rest of World Lung Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 28. Stomach Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Stomach Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Stomach Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Stomach Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Stomach Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 33. Colorectal Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 35. Europe Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 36. Asia-Pacific Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 37. Rest of World Colorectal Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 38. Breast Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 39. North America Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 40. Europe Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 41. Asia-Pacific Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 42. Rest of World Breast Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 43. Prostate Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 44. North America Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 45. Europe Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 46. Asia-Pacific Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 47. Rest of World Prostate Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 48. Liver Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 49. North America Liver Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 50. Europe Liver Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 51. Asia-Pacific Liver Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 52. Rest of World Liver Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 53. Esophagus Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 54. North America Esophagus Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 55. Europe Esophagus Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 56. Asia-Pacific Esophagus Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 57. Rest of World Esophagus Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 58. Cervical Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 59. North America Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 60. Europe Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 61. Asia-Pacific Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 62. Rest of World Cervical Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 63. Kidney Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 64. North America Kidney Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 65. Europe Kidney Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 66. Asia-Pacific Kidney Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 67. Rest of World Kidney Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 68. Bladder Cancer Market Value, By Region, 2022-2031, Million USD
TABLE 69. North America Bladder Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 70. Europe Bladder Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 71. Asia-Pacific Bladder Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 72. Rest of World Bladder Cancer Market Value, By Country, 2022-2031, Million USD
TABLE 73. Other Indications Market Value, By Region, 2022-2031, Million USD
TABLE 74. North America Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 75. Europe Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 76. Asia-Pacific Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 77. Rest of World Other Indications Market Value, By Country, 2022-2031, Million USD
TABLE 78. Global Anti-Cancer Drug Market Value, By Region, 2022-2031, Million USD
TABLE 79. North America Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 80. North America Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 81. North America Anti-Cancer Drug Market Value, By Country, 2022-2031, Million USD
TABLE 82. U.S. Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 83. U.S. Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 84. Canada Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 85. Canada Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 86. Europe Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 87. Europe Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 88. Europe Anti-Cancer Drug Market Value, By Country, 2022-2031, Million USD
TABLE 89. Germany Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 90. Germany Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 91. U.K. Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 92. U.K. Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 93. France Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 94. France Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 95. Italy Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 96. Italy Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 97. Spain Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 98. Spain Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 99. Rest of Europe Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 100. Asia-Pacific Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 101. Asia-Pacific Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 102. Asia-Pacific Anti-Cancer Drug Market Value, By Country, 2022-2031, Million USD
TABLE 103. China Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 104. China Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 105. Japan Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 106. Japan Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 107. South Korea Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 108. South Korea Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 109. India Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 110. India Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 111. Singapore Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 112. Singapore Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 113. Rest of Asia Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 114. Rest of Asia Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 115. Rest of World Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 116. Rest of World Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 117. Rest of World Anti-Cancer Drug Market Value, By Country, 2022-2031, Million USD
TABLE 118. Brazil Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 119. Brazil Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 120. Mexico Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 121. Mexico Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 122. South Africa Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 123. South Africa Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 124. Australia Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 125. Australia Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
TABLE 126. ROW Countries Anti-Cancer Drug Market Value, By Drug Class, 2022-2031, Million USD
TABLE 127. ROW Countries Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD
ROW Countries Anti-Cancer Drug Market Value, By Indication, 2022-2031, Million USD

$2,000
$3,000

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings